399 related articles for article (PubMed ID: 21609640)
1. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
[TBL] [Abstract][Full Text] [Related]
3. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
4. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
6. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
[TBL] [Abstract][Full Text] [Related]
7. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
[TBL] [Abstract][Full Text] [Related]
8. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
9. Use of the levonorgestrel intrauterine system in adolescents with endometriosis.
Yoost J; LaJoie AS; Hertweck P; Loveless M
J Pediatr Adolesc Gynecol; 2013 Apr; 26(2):120-4. PubMed ID: 23518190
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
He SM; Zhang YD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
Kim ML; Cho YJ; Kim MK; Jung YW; Yun BS; Seong SJ
Int J Gynaecol Obstet; 2016 Sep; 134(3):256-9. PubMed ID: 27346551
[TBL] [Abstract][Full Text] [Related]
12. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
[TBL] [Abstract][Full Text] [Related]
15. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
16. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
[TBL] [Abstract][Full Text] [Related]
17. The levonorgestrel intrauterine system: more than a contraceptive.
Andersson K
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():15-22. PubMed ID: 11336429
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
Anpalagan A; Condous G
J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and impact on quality of life of different drug treatments after partial resection of rectovaginal endometriosis].
Li T; Xu XX; Dai Y; Zhang JJ; Lang JH; Leng JH
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):307-313. PubMed ID: 28545268
[No Abstract] [Full Text] [Related]
20. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
